Gene Therapy in Parkinson Disease: From Preclinical Studies in Primates to a Phase I Clinical Trial

被引：0

作者：

Jarraya, B. ^{[1
,3
]}

Lepetit, H. ^{[3
]}

Ralph, S. ^{[2
]}

Miskin, J. ^{[2
]}

Gurruchaga, J-M ^{[3
]}

Fenelon, G. ^{[3
]}

Boulet, S. ^{[1
]}

Jan, C. ^{[1
]}

Bonvento, G. ^{[1
]}

Azzouz, M. ^{[5
]}

Brugiere, P. ^{[3
]}

Kingsman, S. ^{[2
]}

Naylor, S. ^{[2
]}

Hantraye, P. ^{[1
]}

Remy, P. ^{[1
,3
]}

Mazarakis, N. D. ^{[4
]}

Mitrophanous, K. ^{[2
]}

Palfi, S. ^{[1
,3
]}

机构：

[1] CEA CNRS MirCen, Fontenay Aux Roses, France

[2] Oxford BioMed UK Ltd, Oxford, England

[3] Univ Paris, Hop Henri Mondor, Paris, France

[4] Univ London Imperial Coll Sci Technol & Med, Div Med, Dept Gene Therapy, London SW7 2AZ, England

[5] Univ Sheffield, Sch Med, Neurol Unit, Sheffield S10 2TN, S Yorkshire, England

来源：

HUMAN GENE THERAPY | 2010年 / 21卷 / 06期

关键词：

D O I：

暂无

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

引用

页码：764 / 765

页数：2

共 50 条

[21] TCR Gene Therapy of Melanoma: Towards a Phase I Clinical Trial
Jorritsma, Annelies
Gomez, Raquel
Heemskerk, Bianca
Nuijen, Bastiaan
Haanen, John
Schumacher, Ton
MOLECULAR THERAPY, 2009, 17 : S219 - S219
[22] In situ gene therapy for adenocarcinoma of the prostate:: A phase I clinical trial
Herman, JR
Adler, HL
Aguilar-Cordova, E
Rojas-Martinez, A
Woo, S
Timme, TL
Wheeler, TM
Thompson, TC
Scardino, PT
HUMAN GENE THERAPY, 1999, 10 (07) : 1239 - 1249
[23] Non-viral gene therapy for pancreatic cancer, from preclinical models to phase II clinical trial
Buscail, Louis
Bournet, Barbara
Vernejoul, Fabienne
Cambois, Gilles
Lulka, Hubert
Hanoun, Naima
Meulle, Aline
Vignolle-Vidoni, Alix
Barbey, Odile
Gross, Fabian
Guimbaud, Rosine
Ottal, Philippe
Tiraby, Gerard
Cordelier, Pierre
CANCER RESEARCH, 2015, 75
[24] Gene therapy for Parkinson's disease set to enter phase I trials
Butcher, J
LANCET NEUROLOGY, 2002, 1 (08): : 462 - 462
[25] Gene therapy approaches to Parkinson's disease: Preclinical to clinical trials, or what steps to take to get there from here?
Redmond, DE
EXPERIMENTAL NEUROLOGY, 1997, 144 (01) : 160 - 167
[26] Parkinson's Disease, Primates, and Gene Therapy: Vive la Difference?
Lewis, Travis B.
Standaert, David G.
MOVEMENT DISORDERS, 2011, 26 (01) : 2 - 3
[27] DENDRITIC CELL VACCINATION IN POSTREMISSION THERAPY OF AML: RESULTS OF A CLINICAL PHASE I TRIAL AND OF PRECLINICAL STUDIES TESTING COMBINATORIAL APPROACHES
Schnorfeil, F.
Lichtenegger, F.
Rothe, M.
Schlueter, M.
Neitz, J.
Brueggemann, M.
Moosmann, A.
Wagner, B.
Henschler, R.
Koehnke, T.
Buecklein, V.
Altmann, T.
Geiger, C.
Hiddemann, W.
Bigalke, I.
Kvalheim, G.
Schendel, D.
Subklewe, M.
HAEMATOLOGICA, 2015, 100 : 287 - 287
[28] Gene therapy in bestrophinopathies: Insights from preclinical studies in preparation for clinical trials
Amato, Alessia
Wongchaisuwat, Nida
Lamborn, Andrew
Schmidt, Ryan
Everett, Lesley
Yang, Paul
Pennesi, Mark E.
SAUDI JOURNAL OF OPHTHALMOLOGY, 2023, 37 (04) : 287 - 295
[29] Mechanistic Insight from Preclinical Models of Parkinson's Disease Could Help Redirect Clinical Trial Efforts in GDNF Therapy
Delgado-Minjares, Karen M.
Martinez-Fong, Daniel
Martinez-Davila, Irma A.
Banuelos, Cecilia
Gutierrez-Castillo, M. E.
Blanco-Alvarez, Victor Manuel
Cardenas-Aguayo, Maria-del-Carmen
Luna-Munoz, Jose
Pacheco-Herrero, Mar
Soto-Rojas, Luis O.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (21)
[30] Gene therapy trial for Parkinson's disease begins
Oransky, I
LANCET, 2003, 362 (9385): : 712 - 712

← 1 2 3 4 5 →